Next Article in Journal
“Fifty Shades” of Black and Red or How Carboxyl Groups Fine Tune Eumelanin and Pheomelanin Properties
Next Article in Special Issue
Update on the Management of Pediatric Acute Osteomyelitis and Septic Arthritis
Previous Article in Journal
Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series
Previous Article in Special Issue
Exchange Transfusion in the Treatment of Neonatal Septic Shock: A Ten-Year Experience in a Neonatal Intensive Care Unit
Open AccessArticle

Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing

Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp, 2610 Wilrijk, Belgium
Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Wilrijk, Belgium
Clinical Microbiology, Antwerp University Hospital, 2650 Edegem, Belgium
Author to whom correspondence should be addressed.
Academic Editor: Susanna Esposito
Int. J. Mol. Sci. 2016, 17(5), 750;
Received: 25 February 2016 / Revised: 26 April 2016 / Accepted: 9 May 2016 / Published: 17 May 2016
The link between infection with high-risk human papillomavirus (hrHPV) and cervical cancer has been clearly demonstrated. Virological end-points showing the absence of persistent HPV infection are now accepted as a way of monitoring the impact of prophylactic vaccination programs and therapeutic vaccine trials. This study investigated the use of urine samples, which can be collected by self-sampling at home, instead of cervical samples for follow-up of an HPV intervention trial. Eighteen initially HPV DNA-positive women participating in an HPV therapeutic vaccine trial were monitored during a three-year follow-up period. A total of 172 urine samples and 85 cervical samples were collected. We obtained a paired urine sample for each of the 85 cervical samples by recovering urine samples from six monthly gynaecological examinations. We performed a small pilot study in which the participating women used a urine collection device at home and returned their urine sample to the laboratory by mail. All samples were analyzed using quantitative real-time HPV DNA PCR. A good association (κ value of 0.65) was found between the presence of HPV DNA in urine and a subsequent cervical sample. Comparisons of the number of HPV DNA copies in urine and paired cervical samples revealed a significant Spearman rho of 0.676. This correlation was superior in women with severe lesions. The HPV DNA results of the small pilot study based on self-collected urine samples at home are consistent with previous and subsequent urine and/or cervical results. We demonstrated that urine sampling may be a valid alternative to cervical samples for the follow-up of HPV intervention trials or programs. The potential clinical value of urine viral load monitoring should be further investigated. View Full-Text
Keywords: urine; HPV DNA; vaccination; HPV testing; self-sampling urine; HPV DNA; vaccination; HPV testing; self-sampling
Show Figures

Graphical abstract

MDPI and ACS Style

Vorsters, A.; Van Keer, S.; Biesmans, S.; Hens, A.; De Coster, I.; Goossens, H.; Ieven, M.; Van Damme, P. Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing. Int. J. Mol. Sci. 2016, 17, 750.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop